edetic acid has been researched along with carboplatin in 15 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (6.67) | 18.7374 |
| 1990's | 7 (46.67) | 18.2507 |
| 2000's | 5 (33.33) | 29.6817 |
| 2010's | 2 (13.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Andersen, LS; Jakobsen, A; Jakobsen, P; Nielsen, JT; Strömgren, A; Sørensen, BT | 1 |
| Barton, C; Duchesne, G; Fisher, C; Horwich, A; Williams, M | 1 |
| Brunner, V; Bugat, R; Canal, P; Chatelut, E; Chevreau, C; Houin, G; Martinez, M | 1 |
| Benatti, U; De Flora, A; Gasparini, A; Giovine, M; Tonetti, M | 1 |
| Balmanno, K; Calvert, AH; Keir, M; Lewis, IJ; Newell, DR; Pearson, AD; Pinkerton, CR; Price, L; Stevens, MC; Wyllie, RA | 1 |
| Brandt, LJ; Broadbent, V | 1 |
| Black, KL; Cloughesy, T; Farahani, K; Gobin, YP; Grous, J; Hoh, CK; Huang, SC; Nelson, G; Phelps, M; Zhou, Y | 1 |
| Appelius, H; Jaehde, U; Kloft, C; Schunack, W; Siegert, W | 1 |
| Boddy, AV; Calvert, AH; Fenwick, J; Highley, M; McGill, A; Wright, JG | 1 |
| Aird, RE; Chen, H; Cummings, J; Jodrell, DI; Morris, RE; Muir, M; Ritchie, AA; Sadler, PJ | 1 |
| Havsteen, H; Nielsen, LE; Nielsen, SS; Petersen, LK; Rehling, M | 1 |
| Aotani, E; Fujiwara, K; Imafuku, N; Ishikawa, H; Kagawa, R; Kohno, I; Koike, H; Kozuka, Y; Maehata, K; Nagao, S; Oda, T | 1 |
| Boddy, AV; Chinnaswamy, G; Cole, M; English, M; Keir, M; Parry, A; Price, L; Veal, GJ | 1 |
| Forte, C; Gillen, G; Macpherson, IR; Mark, PB; Morrison, P; Shepherd, ST; White, JD | 1 |
| Ainsworth, N; Earl, H; Janowitz, T; Jodrell, DI; Lynch, AG; Mark, PB; Marshall, A; Sammut, SJ; Shepherd, S; Tavaré, S; Thomas, PB; White, J; Williams, EH | 1 |
3 trial(s) available for edetic acid and carboplatin
| Article | Year |
|---|---|
A pharmacologically guided phase I study of carboplatin in combination with methotrexate and vinblastine in advanced urothelial cancer.
Topics: Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Transitional Cell; Cell Count; Edetic Acid; Female; Glomerular Filtration Rate; Humans; Infusions, Intravenous; Kidney Neoplasms; Linear Models; Male; Methotrexate; Middle Aged; Neutropenia; Neutrophils; Thrombocytopenia; Ultrafiltration; Ureteral Neoplasms; Urinary Bladder Neoplasms; Urologic Neoplasms; Vinblastine | 1995 |
Intracarotid infusion of RMP-7, a bradykinin analog, and transport of gallium-68 ethylenediamine tetraacetic acid into human gliomas.
Topics: Adult; Aged; Antineoplastic Agents; Biological Transport; Bradykinin; Brain Neoplasms; Carboplatin; Drug Therapy, Combination; Edetic Acid; Female; Gallium Radioisotopes; Glioma; Humans; Injections, Intra-Arterial; Magnetic Resonance Imaging; Male; Middle Aged; Neoplasm Recurrence, Local; Tomography, Emission-Computed | 1997 |
Estimation of glomerular filtration rate in cancer patients.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antineoplastic Agents; Carboplatin; Chelating Agents; Chromium Radioisotopes; Edetic Acid; Female; Glomerular Filtration Rate; Humans; Male; Middle Aged; Models, Theoretical; Neoplasms | 2001 |
12 other study(ies) available for edetic acid and carboplatin
| Article | Year |
|---|---|
Renal handling of carboplatin.
Topics: Adult; Aged; Carboplatin; Chromium Radioisotopes; Edetic Acid; Female; Humans; Kidney; Middle Aged; Ovarian Neoplasms; Time Factors | 1992 |
The impact of hydronephrosis on renal function in patients treated with cisplatin-based chemotherapy for metastatic nonseminomatous germ cell tumors.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Cisplatin; Edetic Acid; Glomerular Filtration Rate; Humans; Hydronephrosis; Kidney; Lymphatic Metastasis; Male; Middle Aged; Nephrectomy; Organoplatinum Compounds; Testicular Neoplasms; Tomography, X-Ray Computed | 1988 |
Enhanced formation of reactive species from cis-diammine-(1,1-cyclobutanedicarboxylato)-platinum(II) (carboplatin) in the presence of oxygen free radicals.
Topics: Animals; Ascorbic Acid; Carboplatin; Cisplatin; DNA; Drug Stability; Edetic Acid; Ferrous Compounds; Free Radicals; Oxygen; Platinum | 1993 |
Carboplatin pharmacokinetics in children: the development of a pediatric dosing formula. The United Kingdom Children's Cancer Study Group.
Topics: Adolescent; Carboplatin; Child; Child, Preschool; Chromium Radioisotopes; Edetic Acid; Female; Glomerular Filtration Rate; Humans; Infant; Kidney Function Tests; Male; Neoplasms | 1993 |
Nephrotoxicity following carboplatin use in children: is routine monitoring of renal function necessary?
Topics: Adolescent; Carboplatin; Child; Child, Preschool; Chromium Radioisotopes; Drug Administration Schedule; Edetic Acid; Glomerular Filtration Rate; Humans; Infant; Kidney Diseases; Kidney Function Tests; Neoplasms | 1993 |
Determination of platinum complexes in clinical samples by a rapid flameless atomic absorption spectrometry assay.
Topics: Anticoagulants; Antineoplastic Agents; Blood Specimen Collection; Calibration; Carboplatin; Drug Stability; Edetic Acid; Heparin; Humans; Platinum; Reproducibility of Results; Sensitivity and Specificity; Spectrophotometry, Atomic; Temperature; Time Factors; Ultrafiltration | 1999 |
In vitro and in vivo activity and cross resistance profiles of novel ruthenium (II) organometallic arene complexes in human ovarian cancer.
Topics: Animals; Antimetabolites, Antineoplastic; Antineoplastic Agents; ATP Binding Cassette Transporter, Subfamily B, Member 1; Azacitidine; Calcium Channel Blockers; Carboplatin; Cisplatin; Decitabine; Drug Design; Drug Resistance, Multiple; Drug Resistance, Neoplasm; Drug Screening Assays, Antitumor; Edetic Acid; Female; Humans; Ligands; Mice; Mice, Nude; Neoplasm Proteins; Organometallic Compounds; Ovarian Neoplasms; Ruthenium Compounds; Structure-Activity Relationship; Verapamil; Xenograft Model Antitumor Assays | 2002 |
Patients with ovarian cancer have elevated (51)Cr-EDTA plasma clearance early post-operatively.
Topics: Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Ascites; Blood Specimen Collection; Carboplatin; Chromium Radioisotopes; Edetic Acid; Female; Glomerular Filtration Rate; Humans; Metabolic Clearance Rate; Middle Aged; Neoplasm Staging; Ovarian Neoplasms; Postoperative Period; Radionuclide Imaging; Radiopharmaceuticals; Reproducibility of Results; Retrospective Studies; Sensitivity and Specificity; Statistics as Topic | 2002 |
Difference of carboplatin clearance estimated by the Cockroft-Gault, Jelliffe, Modified-Jelliffe, Wright or Chatelut formula.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antineoplastic Agents; Area Under Curve; Carboplatin; Chromium Radioisotopes; Creatinine; Edetic Acid; Female; Genital Neoplasms, Female; Glomerular Filtration Rate; Humans; Middle Aged; Models, Biological; Retrospective Studies | 2005 |
Estimation of renal function and its potential impact on carboplatin dosing in children with cancer.
Topics: Adolescent; Adult; Antineoplastic Agents; Area Under Curve; Carboplatin; Child; Child, Preschool; Dose-Response Relationship, Drug; Edetic Acid; Glomerular Filtration Rate; Humans; Infant; Kidney; Neoplasms; Organometallic Compounds; Radioisotope Renography; Retrospective Studies; Surveys and Questionnaires; Young Adult | 2008 |
Performance of formulae based estimates of glomerular filtration rate for carboplatin dosing in stage 1 seminoma.
Topics: Adult; Antineoplastic Agents; Area Under Curve; Body Mass Index; Body Surface Area; Carboplatin; Chelating Agents; Dose-Response Relationship, Drug; Edetic Acid; Glomerular Filtration Rate; Humans; Male; Middle Aged; Neoplasm Staging; Renal Insufficiency, Chronic; Seminoma; Testicular Neoplasms | 2014 |
New Model for Estimating Glomerular Filtration Rate in Patients With Cancer.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Carboplatin; Chromium Radioisotopes; Edetic Acid; Female; Glomerular Filtration Rate; Humans; Kidney; Linear Models; Male; Middle Aged; Models, Biological; Neoplasms; Young Adult | 2017 |